Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combination effect of lapatinib with foretinib in HER2 and MET co-activated experimental esophageal adenocarcinoma
Md. Sazzad Hassan, Fiona Williams, Niranjan Awasthi, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

Advances and challenges in the treatment of esophageal cancer
Shiming He, Jian Xu, Xiujun Liu, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 11, pp. 3379-3392
Open Access | Times Cited: 187
When the MET receptor kicks in to resist targeted therapies
Marie Fernandes, Philippe Jamme, Alexis B. Cortot, et al.
Oncogene (2021) Vol. 40, Iss. 24, pp. 4061-4078
Closed Access | Times Cited: 34
Nanoparticles targeting Sialyl-Tn for efficient tyrosine kinase inhibitor delivery in gastric cancer
Francisca Diniz, Sofia Lamas, Hugo Osório, et al.
Acta Biomaterialia (2023) Vol. 170, pp. 142-154
Open Access | Times Cited: 12
Therapeutic implications of signaling pathways and tumor microenvironment interactions in esophageal cancer
Inamu Rashid Khan, Hana Q. Sadida, Sheema Hashem, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116873-116873
Open Access | Times Cited: 4
Eosinophilic esophagitis, Barrett’s esophagus and esophageal neoplasms in the pediatric patient: a narrative review
Annette L. Medina, David M. Troendle, Jason Y. Park, et al.
Translational Gastroenterology and Hepatology (2021) Vol. 6, pp. 32-32
Open Access | Times Cited: 21
Characterization of MET Alterations in 37 Gastroesophageal Cancer Cell Lines for MET-Targeted Therapy
Jin‐Soo Kim, Mi Young Kim, Sungyoul Hong
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5975-5975
Open Access | Times Cited: 3
Inhibition of Insulin-like Growth Factor 1 Receptor/Insulin Receptor Signaling by Small-Molecule Inhibitor BMS-754807 Leads to Improved Survival in Experimental Esophageal Adenocarcinoma
Md Sazzad Hassan, Chloe Johnson, Saisantosh Ponna, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3175-3175
Open Access | Times Cited: 2
Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer
Ling Wei, Jujie Sun, Nasha Zhang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 14
Synergistic Effects of Metformin and Trastuzumab on HER2 Positive Gastroesophageal Adenocarcinoma Cells In Vitro and In Vivo
Jin-Soo Kim, M.Y. Kim, Sungyoul Hong
Cancers (2023) Vol. 15, Iss. 19, pp. 4768-4768
Open Access | Times Cited: 5
Characterization of MET Alterations in 37 Gastroesophageal Cancer Cell Lines for MET-Targeted Therapy
Jin‐Soo Kim, M.Y. Kim, Sungyoul Hong
(2024)
Open Access | Times Cited: 1
Therapeutic Potential of the Cyclin-Dependent Kinase Inhibitor Flavopiridol on c-Myc Overexpressing Esophageal Cancer
Md Sazzad Hassan, Nicholas Cwidak, Chloe Johnson, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 10
Structural investigations on mechanism of lapatinib resistance caused by HER-2 mutants
Sharad Verma, Sukriti Goyal, Anchala Kumari, et al.
PLoS ONE (2018) Vol. 13, Iss. 2, pp. e0190942-e0190942
Open Access | Times Cited: 8
Targeted therapy in esophageal cancer
Md Sazzad Hassan, Victoria Makuru, Urs von Holzen
Digestive Medicine Research (2021) Vol. 4, pp. 29-29
Open Access | Times Cited: 5
Syringin as TGF-βR1, HER2, EGFR, FGFR4 Kinase, and MMP-2 Inhibitor and Potential Cytotoxic Agent against ER+ Breast Cancer Cells
Ross D. Vasquez, Charlaine A. Aventurado, Agnes L. Castillo
Current Enzyme Inhibition (2022) Vol. 19, Iss. 1, pp. 55-64
Closed Access | Times Cited: 3
Integrated analysis of ferroptosis and stemness based on single-cell and bulk RNA-sequencing data provide insights into the prognosis and treatment of esophageal carcinoma
Xin Sui, Wenjia Wang, D D Zhang, et al.
Gene (2024) Vol. 927, pp. 148701-148701
Closed Access
The MET Oncogene Network of Interacting Cell Surface Proteins
Simona Gallo, Consolata Beatrice Folco, Tiziana Crepaldi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13692-13692
Open Access
Precision Medicine Revolutionizing Esophageal Cancer Treatment: Surmounting Hurdles and Enhancing Therapeutic Efficacy through Targeted Drug Therapies"
Henu Kumar Verma, Poojarani Panda, L.V.K.S. Bhaskar
(2023)
Open Access | Times Cited: 1
Precision Medicine Revolutionizing Esophageal Cancer Treatment: Surmounting Hurdles and Enhancing Therapeutic Efficacy through Targeted Drug Therapies
Poojarani Panda, Henu Kumar Verma, L.V.K.S. Bhaskar
Onco (2023) Vol. 3, Iss. 3, pp. 127-146
Open Access | Times Cited: 1
Güncel Biyokimya Çalışmaları VII
Yasemin Atıcı, Zeynep Ökten, Sara Kasebi, et al.
(2024)
Open Access
LC–MS/MS assay for the quantification of foretinib in rat plasma and its application to preclinical pharmacokinetic study
Nan Guo, Aiying Zhang, Hui Zhuang, et al.
Biomedical Chromatography (2020) Vol. 34, Iss. 8
Closed Access | Times Cited: 2
Immunotherapy for Esophageal Cancer
Md Sazzad Hassan, Nicholas Cwidak, Urs von Holzen
Springer eBooks (2022), pp. 1-22
Closed Access
Page 1

Scroll to top